<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Phys Ther Sci</journal-id><journal-id journal-id-type="iso-abbrev">J Phys Ther Sci</journal-id><journal-id journal-id-type="publisher-id">JPTS</journal-id><journal-title-group><journal-title>Journal of Physical Therapy Science</journal-title></journal-title-group><issn pub-type="ppub">0915-5287</issn><issn pub-type="epub">2187-5626</issn><publisher><publisher-name>The Society of Physical Therapy Science</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28533623</article-id><article-id pub-id-type="pmc">5430286</article-id><article-id pub-id-type="publisher-id">jpts-2016-836</article-id><article-id pub-id-type="doi">10.1589/jpts.29.748</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Short physical performance battery for middle-aged and older adult
cardiovascular disease patients: implication for strength tests and lower extremity
morphological evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Yasuda</surname><given-names>Tomohiro</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref><xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref><xref rid="cor1" ref-type="corresp">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Fukumura</surname><given-names>Kazuya</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Nakajima</surname><given-names>Toshiaki</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref></contrib><aff id="aff1"><label>1)</label> Graduate School of Medicine, University of Tokyo,
Japan</aff><aff id="aff2"><label>2)</label> School of Nursing, Seirei Christopher University,
Japan</aff><aff id="aff3"><label>3)</label> Faculty of Medicine, Toho University, Japan</aff><aff id="aff4"><label>4)</label> Kanto Central Hospital of the Mutual Aid Association of
Public School Teachers, Japan</aff><aff id="aff5"><label>5)</label> Heart Center, Dokkyo Medical University Hospital,
Japan</aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>Corresponding author. Tomohiro Yasuda, School of Nursing,
Seirei Christopher University: 3453 Mikatahara, Kita-ku, Hamamatsu, Shizuoka 433-8558,
Japan. (E-mail: <email xlink:href="tomohiro-y@seirei.ac.jp">tomohiro-y@seirei.ac.jp</email>)</corresp></author-notes><pub-date pub-type="epub"><day>20</day><month>4</month><year>2017</year></pub-date><pub-date pub-type="ppub"><month>4</month><year>2017</year></pub-date><volume>29</volume><issue>4</issue><fpage>748</fpage><lpage>753</lpage><history><date date-type="received"><day>09</day><month>9</month><year>2016</year></date><date date-type="accepted"><day>18</day><month>1</month><year>2017</year></date></history><permissions><copyright-statement>2017&#x000a9;by the Society of Physical Therapy Science. Published by IPEC
Inc.</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access"><license-p>This is an open-access article distributed under the terms of the Creative
Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License. (CC-BY-NC-ND 4.0:
<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
https://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>&#x0ff09;. </license-p></license></permissions><abstract><p>[Purpose] To examine if the SPPB is higher with healthy subjects than outpatients, which
was higher than inpatients and if the SPPB can be validated assessment tool for strength
tests and lower extremity morphological evaluation in cardiovascular disease patients.
[Subjects and Methods] Twenty-four middle aged and older adults with cardiovascular
disease were recruited from inpatient and outpatient facilities and assigned to separate
experimental groups. Twelve age-matched healthy volunteers were assigned to a control
group. SPPB test was used to assess balance and functional motilities. The test outcomes
were compared with level of care (inpatient vs. outpatient), physical characteristics,
strength and lower extremity morphology. [Results] Total SPPB scores, strength tests (knee
extensor muscle strength), and lower extremity morphological evaluation (muscle thickness
of anterior and posterior mid-thigh and posterior lower-leg) were greater in healthy
subjects and outpatients groups compared with inpatients. To predict total Short Physical
Performance Battery scores, the predicted knee extension and anterior mid-thigh muscle
thickness were calculated. [Conclusion] The SPPB is an effective tool as the strength
tests and lower extremity morphological evaluation for middle-aged and older adult
cardiovascular disease patients. Notably, high knee extensor muscle strength and
quadriceps femoris muscle thickness are positively associated with high SPPB scores.</p></abstract><kwd-group><kwd>SPPB</kwd><kwd>Muscle thickness</kwd><kwd>Quadriceps femoris</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>INTRODUCTION</title><p>Cardiovascular disease (CVD) is a major contributor to the global burden of diseases<xref rid="r1" ref-type="bibr">1</xref>, <xref rid="r2" ref-type="bibr">2</xref><sup>)</sup>. In
addition, CVD (heart failure and stroke, etc.) often causes disuse muscle atrophy in the
acute and subacute phase, which increases the likelihood of wheelchair or bedridden state in
the chronic phase<xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r4" ref-type="bibr">4</xref>,<xref rid="r5" ref-type="bibr">5</xref><sup>)</sup>. Consequently, the
progression of muscle atrophy in lower extremity function may render a high need for medical
and nursing care.</p><p>The Short Physical Performance Battery (SPPB)&#x02014;a brief performance battery based on a timed
short distance walk, repeated chair stands, and a set of balance tests&#x02014;is a validated
assessment tool for measuring lower extremity function that is widely used in both clinical
and research settings<xref rid="r6" ref-type="bibr">6</xref>, <xref rid="r7" ref-type="bibr">7</xref><sup>)</sup>. The popularity of this instrument stems, in part, from its relative
ease of use, perceived potential for implementation in clinical practice, and good
association with physical activity levels and general walking disability in a variety of
patients or older adults. It has also been found to predict mortality, hospitalization rate,
and a variety of comorbid disease conditions<xref rid="r7" ref-type="bibr">7</xref><sup>)</sup>. Although the SPPB is an effective assessment tool for lower
extremity function, it is unclear the SPPB can be used to evaluate mobility capability for
cardiovascular disease patients including inpatients and outpatients. Previous studies
demonstrated that gait speed was associated with survival in older adults and which was
faster with healthy older adults than outpatients, which was faster than inpatients<xref rid="r8" ref-type="bibr">8</xref>, <xref rid="r9" ref-type="bibr">9</xref><sup>)</sup>.
Thus, the purpose of this study was to examine two hypotheses: that the SPPB would be higher
with healthy older adults than outpatients, which was higher than inpatients; and that the
SPPB can be validated assessment tool for strength tests and lower extremity morphological
evaluation in middle-aged and older adult cardiovascular disease patients.</p></sec><sec sec-type="methods" id="s2"><title>SUBJECTS AND METHODS</title><p>Thirty-six middle-aged and older adults, aged 49 to 89&#x02005;years, with cardiovascular diseases
[outpatients (OUT-Pt) and inpatients (IN-Pt)] and healthy subjects (Ctrl) volunteered to
participate in the study and were selected according to the exclusion criteria (history of
anemia, cerebrovascular disease and arthroscopic joint surgery). In addition, volunteers who
suffered from a chronic disease such as severe orthopedic disorders, peripheral vascular
disease, or cognitive dysfunction were excluded from the study. All participants had
undergone complete chemistry and hematologic evaluation and were informed of the risks
associated with involvement in the study and signed an informed consent document before
participation. All participants were recruited through study notices in area and oral
communications in the university hospital. The principles of the World Medical Association
Declaration of Helsinki and the American College of Sports Medicine Guidelines for Use of
Human Subjects were adopted in this study. The study was approved by the Ethics Committee of
the University. Analyses of ultrasound images and all measurements data were performed by
the same author, who was blinded to the group assignments. The author has been specialized
in the research of exercise physiology by use of ultrasound images, strength tests and lower
extremity morphological evaluation more than 15&#x02005;years.</p><p>Participants performed the SPPB according to the National Institute on Aging protocol. The
tests were performed in the following sequence: a) standing balance tests, b) gait test, and
c) chair stand test. The standing balance portion requires participants to maintain, for 10
seconds each, stances with their feet placed side by side, semi-tandem, and in tandem. The
scores ranged from 0 to 4 (maximum performance). The gait test measured the time needed to
walk 4&#x02005;m at a typical pace. The chair stand required participants to rise from a steel
chair, 0.40&#x02005;m height and 0.30&#x02005;m depth, with their arms across their chest, five times.
Categorical scores, range: 0&#x02212;4, for both the gait and the chair stand tests were based on
timed quartiles established previously in a large population. Individuals who were unable to
complete either the 4&#x02005;m gait task or the 5 repetitions chair stand test received a score of
0. The sum of the three components comprised the final SPPB score, with a possible range
from 0 to 12. A score of 12 indicated the highest degree of lower extremity function<xref rid="r6" ref-type="bibr">6</xref>, <xref rid="r10" ref-type="bibr">10</xref><sup>)</sup>.</p><p>Maximum voluntary isometric contraction (MVIC) of the handgrip was determined using a
factory-calibrated hand dynamometer (TKK 5401, TAKEI Scientific Instruments Co., Ltd.,
Tokyo, Japan). All subjects were instructed to maintain an upright standing position, arms
at their side, holding the dynamometer in the right hand with the arm at a right angle and
the elbow held at the side of the body. The size of the dynamometer handle was set so that
it felt comfortable to the subject while squeezing the grip. Each subject underwent 2
trials, and the best value of 2 trials was used for analysis.</p><p>MVIC of the knee extensors was determined using a digital handheld dynamometer (&#x003bc;Tas MT-1,
ANIMA Co., Ltd., Tokyo, Japan)<xref rid="r11" ref-type="bibr">11</xref><sup>)</sup>. The
dynamometer pad is 55 &#x000d7; 55&#x02005;mm, and its front side is curved to fit the shape of the area of
the extremity to be measured. Subjects were seated in a hard chair with their knees flexed
90&#x000b0; and their arms on their thighs. The dynamometer was placed perpendicular to the leg just
above the malleoli. During all tests, the dynamometer was kept stable by the examiner using
both hands and the subject&#x02019;s leg was fixed by a belt to keep the knee flexed at 90&#x000b0;.
Subjects were told to push against the dynamometer by attempting to straighten their leg.
They were asked to build force gradually to a maximum voluntary effort. Each subject was
given 2 trials with an interval of at least 2&#x02005;min between the trials. The highest score was
adopted for the individual data.</p><p>Percent body fat and fat-free mass were measured using leg-to-leg bioelectrical impedance
analysis (Reactance Technology, Inner Scan, TANITA, Tokyo, Japan). The measurements were
carried out while the subjects stood with their elbows extended and relaxed.</p><p>After thigh and lower leg length measurements using anatomic landmarks, all measurement
sites were marked with a marker pen and then mid-thigh, at 50% between the lateral condyle
of the femur and the greater trochanter, and lower-leg, at 30% proximal between the lateral
malleolus of the fibula and the lateral condyle of the tibia, girths and were measured using
a tape measure on the right side of the body<xref rid="r12" ref-type="bibr">12</xref><sup>)</sup>. Ultrasound evaluation of muscle thickness (MTH) was performed by
using a real-time linear electronic scanner with a 10.0-MHz scanning head (5.5&#x02005;cm length
probe, ProSound C3CV, Hitachi Aloka System, Tokyo, Japan). The scanning head was coated with
a water-soluble transmission gel to provide acoustic contact without depressing the dermal
surface. The subcutaneous adipose tissue-muscle interface and the muscle-bone interface were
identified from the ultrasonic image. The perpendicular distance from the adipose
tissue-muscle interface to the muscle-bone interface was considered to represent MTH.
Briefly, the measurements were carried out while the subjects stood with their elbows
extended and relaxed<xref rid="r12" ref-type="bibr">12</xref><sup>)</sup>.</p><p>Results are expressed as mean &#x000b1; standard deviation for all variables. All data were
analyzed using JMP software v.12.0 for Mac (SAS Institute Inc., Tokyo, Japan). Pearson
product correlations of tandem, or Chair stand, or gait or total SPPB scores and variable
factors were also statistically quantified. When the data were not normally distributed,
non-parametric statistical analysis, Wilcoxon signed rank test, was used to identify
differences in IN-Pt vs. OUT-Pt vs. Ctrl groups. A stepwise multiple-regression analysis
(method of increasing and decreasing the variables, criterion was set at p&#x0003c;0.05) was
performed to develop a prediction equation for SPPB scores using age, height, weight, BMI,
%BF, systolic and diastolic blood pressures, resting heart rate, handgrip, knee extension,
fat free-mass, mid-thigh and lower-leg girths, and anterior mid-thigh, posterior mid-thigh,
and posterior lower-leg MTHs as independent variables. Consequently, the predicted
variables, coefficients and intercept coefficients were automatically picked out by the JMP
software. Statistical significance was set at p&#x0003c;0.05. The sample size was estimated from
a priori power analysis to detect the correlation (power of 0.80, an &#x003b1; of 0.05, two-tailed,
and &#x003c1;=0.5) with the reference<xref rid="r13" ref-type="bibr">13</xref><sup>)</sup>.
Consequently, it was determined that a minimum of 29 participants was required.</p></sec><sec sec-type="results" id="s3"><title>RESULTS</title><p>The physical characteristics and clinical data are shown in <xref rid="tbl_001" ref-type="table">Table 1</xref><table-wrap id="tbl_001" orientation="portrait" position="float"><label>Table
1.</label><caption><title>The physical characteristics and clinical
data</title></caption><table frame="hsides" rules="groups"><col width="40.4762%" span="1"/><col width="19.8413%" span="1"/><col width="19.8413%" span="1"/><col width="19.8413%" span="1"/><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1">IN-Pt </th><th valign="top" align="center" rowspan="1" colspan="1">OUT-Pt </th><th valign="top" align="center" rowspan="1" colspan="1">Ctrl
</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Male (n)</td><td align="center" valign="top" rowspan="1" colspan="1">7</td><td align="center" valign="top" rowspan="1" colspan="1">7</td><td align="center" valign="top" rowspan="1" colspan="1">7</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Female
(n)</td><td align="center" valign="top" rowspan="1" colspan="1">5</td><td align="center" valign="top" rowspan="1" colspan="1">5</td><td align="center" valign="top" rowspan="1" colspan="1">5</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Age (years)</td><td align="center" valign="top" rowspan="1" colspan="1">71.8 (11.6)</td><td align="center" valign="top" rowspan="1" colspan="1">70.3 (8.1)</td><td align="center" valign="top" rowspan="1" colspan="1">70.0
(6.7)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Height (cm)</td><td align="center" valign="top" rowspan="1" colspan="1">160 (14)</td><td align="center" valign="top" rowspan="1" colspan="1">162 (10)</td><td align="center" valign="top" rowspan="1" colspan="1">164 (9)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Weight (kg)</td><td align="center" valign="top" rowspan="1" colspan="1">59.8 (14.0)</td><td align="center" valign="top" rowspan="1" colspan="1">60.9 (10.0)</td><td align="center" valign="top" rowspan="1" colspan="1">58.9
(7.1)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Body mass index
(kg/m<sup>2</sup>)</td><td align="center" valign="top" rowspan="1" colspan="1">23.6 (6.5)</td><td align="center" valign="top" rowspan="1" colspan="1">23.3 (3.0)</td><td align="center" valign="top" rowspan="1" colspan="1">22.0
(1.4)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">% body fat</td><td align="center" valign="top" rowspan="1" colspan="1">30.1 (17.5)</td><td align="center" valign="top" rowspan="1" colspan="1">24.0 (7.6)</td><td align="center" valign="top" rowspan="1" colspan="1">23.1 (6.4)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Systolic BP (mmHg)</td><td align="center" valign="top" rowspan="1" colspan="1">113 (24)</td><td align="center" valign="top" rowspan="1" colspan="1">133 (19)</td><td align="center" valign="top" rowspan="1" colspan="1">137 (19)
<sup>#</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Diastolic BP
(mmHg)</td><td align="center" valign="top" rowspan="1" colspan="1">64 (14)</td><td align="center" valign="top" rowspan="1" colspan="1"> 71 (11)</td><td align="center" valign="top" rowspan="1" colspan="1"> 82 (12)
<sup>##</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Resting heart rate
(bpm)</td><td align="center" valign="top" rowspan="1" colspan="1"> 79 (12)</td><td align="center" valign="top" rowspan="1" colspan="1"> 71 (12)</td><td align="center" valign="top" rowspan="1" colspan="1"> 73 (8)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BNP&#x02005;(pg/m1)</td><td align="center" valign="top" rowspan="1" colspan="1">177 (170) *</td><td align="center" valign="top" rowspan="1" colspan="1"> 62 (46)</td><td align="center" valign="top" rowspan="1" colspan="1">-</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hospital admission (within
10&#x02005;years)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Number</td><td align="center" valign="top" rowspan="1" colspan="1"> 2.9 (2.2)</td><td align="center" valign="top" rowspan="1" colspan="1"> 2.0
(1.9)</td><td align="center" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Duration (days)</td><td align="center" valign="top" rowspan="1" colspan="1">49.3 (53.5)</td><td align="center" valign="top" rowspan="1" colspan="1">23.1 (24.2) </td><td align="center" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Specific diseases (n)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Vascular diseases</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Ischemic
heart diseases </td><td align="center" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1"> 10</td><td align="center" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Valvular diseases</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Congestive heart failure</td><td align="center" valign="top" rowspan="1" colspan="1">7</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hypertension</td><td align="center" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1">9</td><td align="center" valign="top" rowspan="1" colspan="1">0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Others
</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">0 </td></tr></tbody></table><table-wrap-foot><p>Data are
given as mean (standard deviation). BNP: brain natriuretic peptide; BP: blood
pressure. Others, myocarditis, deep vein thrombosis, etc. *p&#x0003c;0.05, IN-Pt vs.
OUT-Pt. <sup>##</sup>p&#x0003c;0.01, <sup>#</sup>p&#x0003c;0.05, IN-Pt vs.
Ctrl</p></table-wrap-foot></table-wrap>. There were no significant differences among
three conditions in physical characteristics except for systolic and diastolic blood
pressures. Total SPPB scores, strength tests, and morphological assessments were greater in
the Ctrl and the OUT-Pt groups compared with the IN-Pt group (<xref rid="tbl_002" ref-type="table">Table 2</xref><table-wrap id="tbl_002" orientation="portrait" position="float"><label>Table
2.</label><caption><title>Short physical performance battery (SPPB), strength tests,
and morphological assessments</title></caption><table frame="hsides" rules="groups"><col width="41.8605%" span="1"/><col width="19.3798%" span="1"/><col width="19.3798%" span="1"/><col width="19.3798%" span="1"/><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1">IN-Pt</th><th valign="top" align="center" rowspan="1" colspan="1">OUT-Pt</th><th valign="top" align="center" rowspan="1" colspan="1">Ctrl </th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">SPPB (raw
data)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Side-by-side
stand (sec)</td><td align="center" valign="top" rowspan="1" colspan="1">10.0 (0.0)</td><td align="center" valign="top" rowspan="1" colspan="1">10.0 (0.0)</td><td align="center" valign="top" rowspan="1" colspan="1">10.0
(0.0)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Semi-tandem stand (sec)</td><td align="center" valign="top" rowspan="1" colspan="1">10.0 (0.0)</td><td align="center" valign="top" rowspan="1" colspan="1">10.0
(0.0)</td><td align="center" valign="top" rowspan="1" colspan="1">10.0 (0.0)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Tandem stand (sec)</td><td align="center" valign="top" rowspan="1" colspan="1"> 7.1
(3.6)</td><td align="center" valign="top" rowspan="1" colspan="1">8.3 (3.1)</td><td align="center" valign="top" rowspan="1" colspan="1">10.0 (0.0) <sup>##</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Gait test (sec/4m)</td><td align="center" valign="top" rowspan="1" colspan="1"> 5.4 (3.2)</td><td align="center" valign="top" rowspan="1" colspan="1"> 3.8 (0.6) *</td><td align="center" valign="top" rowspan="1" colspan="1"> 3.4
(0.3) <sup>##</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Chair stand test
(sec/5rep)</td><td align="center" valign="top" rowspan="1" colspan="1">16.0 (5.0)</td><td align="center" valign="top" rowspan="1" colspan="1">10.0 (1.7) **</td><td align="center" valign="top" rowspan="1" colspan="1"> 7.4 (1.7) <sup>##,
&#x000a7;&#x000a7;</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">SPPB score</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Side-by-side stand</td><td align="center" valign="top" rowspan="1" colspan="1"> 1.0 (0.0) </td><td align="center" valign="top" rowspan="1" colspan="1">1.0 (0.0)
</td><td align="center" valign="top" rowspan="1" colspan="1">1.0 (0.0)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Semi-tandem stand </td><td align="center" valign="top" rowspan="1" colspan="1"> 1.0 (0.0)
</td><td align="center" valign="top" rowspan="1" colspan="1">1.0 (0.0) </td><td align="center" valign="top" rowspan="1" colspan="1">1.0 (0.0)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Tandem stand</td><td align="center" valign="top" rowspan="1" colspan="1"> 1.3 (0.8) </td><td align="center" valign="top" rowspan="1" colspan="1">1.6 (0.8)
</td><td align="center" valign="top" rowspan="1" colspan="1">2.0 (0.0) <sup>##</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Gait test</td><td align="center" valign="top" rowspan="1" colspan="1"> 3.5 (1.0)
</td><td align="center" valign="top" rowspan="1" colspan="1">3.9 (0.3) </td><td align="center" valign="top" rowspan="1" colspan="1">4.0 (0.0)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Chair stand test</td><td align="center" valign="top" rowspan="1" colspan="1"> 2.2 (1.3)</td><td align="center" valign="top" rowspan="1" colspan="1"> 3.7 (0.5)
**</td><td align="center" valign="top" rowspan="1" colspan="1">4.0 (0.0) <sup>##, &#x000a7;</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Total SPPB </td><td align="center" valign="top" rowspan="1" colspan="1"> 9.0
(2.4)</td><td align="center" valign="top" rowspan="1" colspan="1"> 11.2 (1.0) *</td><td align="center" valign="top" rowspan="1" colspan="1">12.0 (0.0) <sup>##, &#x000a7;&#x000a7;</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Strength test</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Handgrip&#x02005;(kg)</td><td align="center" valign="top" rowspan="1" colspan="1">24.1 (9.8)</td><td align="center" valign="top" rowspan="1" colspan="1">28.6 (8.6)</td><td align="center" valign="top" rowspan="1" colspan="1">29.3
(7.2)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Knee extension&#x02005;(kg)</td><td align="center" valign="top" rowspan="1" colspan="1">19.7 (9.9)</td><td align="center" valign="top" rowspan="1" colspan="1">34.9 (10.3)
**</td><td align="center" valign="top" rowspan="1" colspan="1">37.4 (6.3) <sup>##</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Morphological assessment</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Fat free-mass (kg)</td><td align="center" valign="top" rowspan="1" colspan="1">40.9 (11.4)</td><td align="center" valign="top" rowspan="1" colspan="1">46.2 (8.4)</td><td align="center" valign="top" rowspan="1" colspan="1">43.5 (10.2)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mid-thigh girth (cm)</td><td align="center" valign="top" rowspan="1" colspan="1">43.8 (8.1)</td><td align="center" valign="top" rowspan="1" colspan="1">46.3 (3.3)</td><td align="center" valign="top" rowspan="1" colspan="1">45.0
(6.2)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Lower-leg girth (cm)</td><td align="center" valign="top" rowspan="1" colspan="1">33.1 (5.2)</td><td align="center" valign="top" rowspan="1" colspan="1">35.3
(2.4)</td><td align="center" valign="top" rowspan="1" colspan="1">34.2 (4.1)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Anterior mid-thigh MTH (cm)</td><td align="center" valign="top" rowspan="1" colspan="1">3.13
(0.89) </td><td align="center" valign="top" rowspan="1" colspan="1">4.28 (0.74) **</td><td align="center" valign="top" rowspan="1" colspan="1">4.34 (0.60) <sup>##</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Posterior mid-thigh MTH (cm)</td><td align="center" valign="top" rowspan="1" colspan="1">5.06 (0.78)
</td><td align="center" valign="top" rowspan="1" colspan="1">6.05 (0.51) **</td><td align="center" valign="top" rowspan="1" colspan="1">5.55 (0.81) <sup>#</sup></td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Posterior lower-leg MTH (cm)</td><td align="center" valign="top" rowspan="1" colspan="1">5.59
(0.82)</td><td align="center" valign="top" rowspan="1" colspan="1"> 6.52 (0.61) **</td><td align="center" valign="top" rowspan="1" colspan="1">6.46 (0.50)
<sup>##</sup></td></tr></tbody></table><table-wrap-foot><p>N=36. Data are given as
mean (standard deviation). MTH: muscle thickness. **p&#x0003c;0.01, *p&#x0003c;0.05, IN-Pt vs.
OUT-Pt. <sup>##</sup>p&#x0003c;0.01, <sup>#</sup>p&#x0003c;0.05, IN-Pt vs. Ctrl.
<sup>&#x000a7;&#x000a7;</sup>p&#x0003c;0.01, <sup>&#x000a7;</sup>p&#x0003c;0.05, OUT-Pt vs.
Ctrl</p></table-wrap-foot></table-wrap>). Pearson&#x02019;s correlation coefficients between SPPB
scores and variable factors are shown in <xref rid="tbl_003" ref-type="table">Table
3</xref><table-wrap id="tbl_003" orientation="portrait" position="float"><label>Table 3.</label><caption><title>Pearson&#x02019;s
correlation coefficients between SPPB scores and variable
factors</title></caption><table frame="hsides" rules="groups"><col width="31.7481%" span="1"/><col width="17.063%" span="1"/><col width="17.063%" span="1"/><col width="17.063%" span="1"/><col width="17.063%" span="1"/><thead><tr><th valign="top" align="center" rowspan="1" colspan="1"/><th colspan="4" valign="top" align="center" rowspan="1">Pearson&#x02019;s correlation</th></tr><tr><th colspan="5" rowspan="1"><hr/></th></tr><tr><th valign="top" align="center" rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1">Tandem</th><th valign="top" align="center" rowspan="1" colspan="1">Chair
stand</th><th valign="top" align="center" rowspan="1" colspan="1">Gait </th><th valign="top" align="center" rowspan="1" colspan="1">Total SPPB scores </th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Strength test</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Handgrip</td><td align="center" valign="top" rowspan="1" colspan="1">0.432
**</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.527 **</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.523 **</td><td align="center" valign="top" rowspan="1" colspan="1">0.562 **</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Knee extension</td><td align="center" valign="top" rowspan="1" colspan="1">0.382
*</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.717 **</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.491 **</td><td align="center" valign="top" rowspan="1" colspan="1">0.690 **</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Morphological assessment</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Fat
free-mass</td><td align="center" valign="top" rowspan="1" colspan="1">0.369 *</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.386 *</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.429 **</td><td align="center" valign="top" rowspan="1" colspan="1">0.366 *</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mid-thigh girth</td><td align="center" valign="top" rowspan="1" colspan="1">0.233</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.548 **</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.364 *</td><td align="center" valign="top" rowspan="1" colspan="1">0.464 **</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Lower-leg girth</td><td align="center" valign="top" rowspan="1" colspan="1">0.264</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.598 **</td><td align="center" valign="top" rowspan="1" colspan="1"> &#x02212;0.409 *</td><td align="center" valign="top" rowspan="1" colspan="1">0.436 **</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Anterior mid-thigh MTH</td><td align="center" valign="top" rowspan="1" colspan="1">0.463 **</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.802 **</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.569
**</td><td align="center" valign="top" rowspan="1" colspan="1">0.759 **</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Posterior mid-thigh MTH</td><td align="center" valign="top" rowspan="1" colspan="1">0.488
**</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.472 **</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.465 **</td><td align="center" valign="top" rowspan="1" colspan="1">0.563 **</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Posterior lower-leg MTH</td><td align="center" valign="top" rowspan="1" colspan="1">0.437 **</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.670 **</td><td align="center" valign="top" rowspan="1" colspan="1"> &#x02212;0.583 **</td><td align="center" valign="top" rowspan="1" colspan="1">0.655
**</td></tr></tbody></table><table-wrap-foot><p>N=36. Data are given as mean
(standard deviation). MTH: muscle thickness. **p&#x0003c;0.01,
*p&#x0003c;0.05</p></table-wrap-foot></table-wrap>.</p><p>To predict tandem stand, the predicted age and posterior mid-thigh muscle thickness were
calculated (tandem stand=1.80 &#x000d7; posterior mid-thigh muscle thickness &#x02212; 0.10 &#x000d7; age + 5.43)
(n=36, R<sup>2</sup>=0.331, p&#x0003c;0.05). To predict chair stand, the predicted fat free-mass,
knee extension and anterior mid-thigh muscle thickness were calculated (chair stand=0.21 &#x000d7;
fat-free mass &#x02212; 3.21 &#x000d7; anterior mid-thigh muscle thickness &#x02212; 0.25 &#x000d7; knee extension MVIC +
22.34] (R<sup>2</sup>=0.776, p&#x0003c;0.01). To predict gait test, the predicted posterior
lower-leg muscle thickness was only calculated (gait test= &#x02212;1.51 &#x000d7; posterior lower-leg
muscle thickness + 13.59) (R<sup>2</sup>=0.340, p&#x0003c;0.01). To predict total SPPB scores,
the predicted knee extension and anterior mid-thigh muscle thickness were calculated (total
SPPB scores=0.05 &#x000d7; knee extension MVIC + 1.15 &#x000d7;anterior mid-thigh muscle thickness + 4.60)
(R<sup>2</sup>=0.630, p&#x0003c;0.05).</p></sec><sec sec-type="discussion" id="s4"><title>DISCUSSION</title><p>The main findings of this study were as follows. First, total SPPB scores were greater with
Ctrl group than OUT-Pt group, which was higher than IN-Pt group. Second, knee extension
strength and anterior mid-thigh muscle thickness can predict total SPPB scores in
middle-aged and older adult cardiovascular disease patients.</p><p>The SPPB assessment was established as a disability evaluation for older adults, healthy
elderly and some disability conditions<xref rid="r6" ref-type="bibr">6</xref>, <xref rid="r14" ref-type="bibr">14</xref>,<xref rid="r15" ref-type="bibr">15</xref>,<xref rid="r16" ref-type="bibr">16</xref><sup>)</sup>. A previous study reported that impaired
mobility was reflected by a total SPPB score of less than 10<xref rid="r14" ref-type="bibr">14</xref><sup>)</sup>. In addition, total SPPB scores of 4&#x02013;6 were 4.2 to 4.9 times more
likely to have disability in the activities of daily living or mobility-related disability
at 4&#x02005;years. On the other hand, those with total SPPB scores of 7&#x02013;9 were 1.6 to 1.8 times
more likely to become disabled<xref rid="r17" ref-type="bibr">17</xref><sup>)</sup>. In this
study, the average of total SPPB scores in IN-Pt group was 9.0 and scores of 4&#x02013;6 were only
in 2 patients. In addition, there was no patient with a score of 0&#x02013;3. However, a stepwise
multiple-regression analysis could be applied to the predictor knee extension and anterior
mid-thigh muscle thickness to predict total SPPB scores. These results suggested that the
total SPPB scores could be evaluated by the strength tests and morphological assessment in
knee extensor muscles for middle-aged and older adult cardiovascular disease patients, even
if severely impaired mobility patients were very few within the group.</p><p>In this study, the scores in side-by-side, semi-tandem stand and gait test were similar
among the three groups. In contrast, the chair stand test (4 out of 12 score) makes up a
large part of total SPPB scores compared with tandem stand (2 out of 12 score), suggesting
that the differences of total SPPB scores were mainly dependent on the chair stand test. It
is well known that knee extension muscle size and strength play an important role in the
chair stand performance for older adults<xref rid="r18" ref-type="bibr">18</xref>, <xref rid="r19" ref-type="bibr">19</xref><sup>)</sup>. Additionally, knee extension muscle size
and strength were higher correlation coefficients with chair stand test, compared with
balance and gait tests in this study. Thus, it appears that the total SPPB scores were
largely affected by muscle strength and size of the quadriceps femoris.</p><p>The limitation of this study was very difficult to evaluate the function and morphological
assessment within the same hospital admission for IN-Pt group or the same hospital visit for
the OUT-Pt group. Additional research into these issues is needed.</p><p>In conclusion, the SPPB is an effective tool as the strength tests and lower extremity
morphological evaluation for middle-aged and older adult cardiovascular disease patients.
Notably, high knee extensor muscle strength and quadriceps femoris muscle thickness are
positively associated with high SPPB scores.</p><sec><title>Conflicts of interest</title><p>The authors have no conflicts of interest to declare.</p></sec></sec></body><back><ack><p>The authors would like to thank the individuals who participated in this study. This study
was supported, in part, by Grant-in-aid (No. 15K01553 to TY) from the Japan Ministry of
Education, Culture, Sports, Science, and Technology, the Vehicle Racing Commemorative
Foundation (to TN), and Fukuda Foundation for Medical Technology (to TN).</p></ack><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group><name><surname>Murray</surname><given-names>CJ</given-names></name><name><surname>Ortblad</surname><given-names>KF</given-names></name><name><surname>Guinovart</surname><given-names>C</given-names></name><etal>et
al.</etal></person-group>: <article-title>Global, regional, and national incidence and
mortality for HIV, tuberculosis, and malaria during 1990&#x02013;2013: a systematic analysis for
the Global Burden of Disease Study 2013</article-title>. <source>Lancet</source>,
<year>2014</year>, <volume>384</volume>: <fpage>1005</fpage>&#x02013;<lpage>1070</lpage>.
<pub-id pub-id-type="pmid">25059949</pub-id></mixed-citation></ref><ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group><name><surname>Ohira</surname><given-names>T</given-names></name><name><surname>Iso</surname><given-names>H</given-names></name></person-group>:
<article-title>Cardiovascular disease epidemiology in Asia: an overview</article-title>.
<source>Circ J</source>, <year>2013</year>, <volume>77</volume>:
<fpage>1646</fpage>&#x02013;<lpage>1652</lpage>. <pub-id pub-id-type="pmid">23803294</pub-id></mixed-citation></ref><ref id="r3"><label>3</label><mixed-citation publication-type="journal"><person-group><name><surname>Arpaia</surname><given-names>G</given-names></name><name><surname>Bavera</surname><given-names>PM</given-names></name><name><surname>Caputo</surname><given-names>D</given-names></name><etal>et
al.</etal></person-group>: <article-title>Risk of deep venous thrombosis (DVT) in
bedridden or wheelchair-bound multiple sclerosis patients: a prospective
study</article-title>. <source>Thromb Res</source>, <year>2010</year>,
<volume>125</volume>: <fpage>315</fpage>&#x02013;<lpage>317</lpage>. <pub-id pub-id-type="pmid">19640570</pub-id></mixed-citation></ref><ref id="r4"><label>4</label><mixed-citation publication-type="journal"><person-group><name><surname>Naritomi</surname><given-names>H</given-names></name><name><surname>Moriwaki</surname><given-names>H</given-names></name><name><surname>Metoki</surname><given-names>N</given-names></name><etal>et
al.</etal></person-group>MARVELOUS (Muscular Atrophy Restraint with Vigilant Edaravone
Long-term Use after Stroke) Study Group: <article-title>Effects of edaravone on muscle
atrophy and locomotor function in patients with ischemic stroke: a randomized controlled
pilot study</article-title>. <source>Drugs R D</source>, <year>2010</year>,
<volume>10</volume>: <fpage>155</fpage>&#x02013;<lpage>163</lpage>. <pub-id pub-id-type="pmid">20945946</pub-id></mixed-citation></ref><ref id="r5"><label>5</label><mixed-citation publication-type="journal"><person-group><name><surname>Naritomi</surname><given-names>H</given-names></name><name><surname>Moriwaki</surname><given-names>H</given-names></name></person-group>:
<article-title>Prevention of post-stroke disuse muscle atrophy with a free radical
scavenger</article-title>. <source>Front Neurol Neurosci</source>, <year>2013</year>,
<volume>32</volume>: <fpage>139</fpage>&#x02013;<lpage>147</lpage>. <pub-id pub-id-type="pmid">23859973</pub-id></mixed-citation></ref><ref id="r6"><label>6</label><mixed-citation publication-type="journal"><person-group><name><surname>Guralnik</surname><given-names>JM</given-names></name><name><surname>Simonsick</surname><given-names>EM</given-names></name><name><surname>Ferrucci</surname><given-names>L</given-names></name><etal>et
al.</etal></person-group>: <article-title>A short physical performance battery assessing
lower extremity function: association with self-reported disability and prediction of
mortality and nursing home admission</article-title>. <source>J Gerontol</source>,
<year>1994</year>, <volume>49</volume>: <fpage>M85</fpage>&#x02013;<lpage>M94</lpage>.
<pub-id pub-id-type="pmid">8126356</pub-id></mixed-citation></ref><ref id="r7"><label>7</label><mixed-citation publication-type="journal"><person-group><name><surname>Stookey</surname><given-names>AD</given-names></name><name><surname>Katzel</surname><given-names>LI</given-names></name><name><surname>Steinbrenner</surname><given-names>G</given-names></name><etal>et
al.</etal></person-group>: <article-title>The short physical performance battery as a
predictor of functional capacity after stroke</article-title>. <source>J Stroke
Cerebrovasc Dis</source>, <year>2014</year>, <volume>23</volume>:
<fpage>130</fpage>&#x02013;<lpage>135</lpage>. <pub-id pub-id-type="pmid">23253531</pub-id></mixed-citation></ref><ref id="r8"><label>8</label><mixed-citation publication-type="journal"><person-group><name><surname>Peel</surname><given-names>NM</given-names></name><name><surname>Kuys</surname><given-names>SS</given-names></name><name><surname>Klein</surname><given-names>K</given-names></name></person-group>:
<article-title>Gait speed as a measure in geriatric assessment in clinical settings: a
systematic review</article-title>. <source>J Gerontol A Biol Sci Med Sci</source>,
<year>2013</year>, <volume>68</volume>: <fpage>39</fpage>&#x02013;<lpage>46</lpage>.
<pub-id pub-id-type="pmid">22923430</pub-id></mixed-citation></ref><ref id="r9"><label>9</label><mixed-citation publication-type="journal"><person-group><name><surname>Studenski</surname><given-names>S</given-names></name><name><surname>Perera</surname><given-names>S</given-names></name><name><surname>Patel</surname><given-names>K</given-names></name><etal>et
al.</etal></person-group>: <article-title>Gait speed and survival in older
adults</article-title>. <source>JAMA</source>, <year>2011</year>, <volume>305</volume>:
<fpage>50</fpage>&#x02013;<lpage>58</lpage>. <pub-id pub-id-type="pmid">21205966</pub-id></mixed-citation></ref><ref id="r10"><label>10</label><mixed-citation publication-type="journal"><person-group><name><surname>Bernabeu-Mora</surname><given-names>R</given-names></name><name><surname>Medina-Mirapeix</surname><given-names>F</given-names></name><name><surname>Llamazares-Herr&#x000e1;n</surname><given-names>E</given-names></name><etal>et
al.</etal></person-group>: <article-title>The short physical performance battery is a
discriminative tool for identifying patients with COPD at risk of
disability</article-title>. <source>Int J Chron Obstruct Pulmon Dis</source>,
<year>2015</year>, <volume>10</volume>: <fpage>2619</fpage>&#x02013;<lpage>2626</lpage>.
<pub-id pub-id-type="pmid">26664110</pub-id></mixed-citation></ref><ref id="r11"><label>11</label><mixed-citation publication-type="journal"><person-group><name><surname>Watanabe</surname><given-names>M</given-names></name><name><surname>Suzuki</surname><given-names>M</given-names></name><name><surname>Sugimura</surname><given-names>Y</given-names></name><etal>et
al.</etal></person-group>: <article-title>The relationship between bilateral knee muscle
strength and gait performance after stroke: the predictive value for gait
performance</article-title>. <source>J Phys Ther Sci</source>, <year>2015</year>,
<volume>27</volume>: <fpage>3227</fpage>&#x02013;<lpage>3232</lpage>. <pub-id pub-id-type="pmid">26644680</pub-id></mixed-citation></ref><ref id="r12"><label>12</label><mixed-citation publication-type="journal"><person-group><name><surname>Abe</surname><given-names>T</given-names></name><name><surname>Kawakami</surname><given-names>Y</given-names></name><name><surname>Kondo</surname><given-names>M</given-names></name><etal>et
al.</etal></person-group>: <article-title>Prediction equations for body composition of
Japanese adults by B-mode ultrasound</article-title>. <source>Am J Hum Biol</source>,
<year>1994</year>, <volume>6</volume>: <fpage>161</fpage>&#x02013;<lpage>170</lpage>.
</mixed-citation></ref><ref id="r13"><label>13</label><mixed-citation publication-type="book"><person-group><name><surname>Cohen</surname><given-names>J</given-names></name></person-group>: Statistical
power analysis for the behavioral sciences, 2nd ed. Hillsdale, New Jersey: Lawrence
Erlbaum Associates Inc., <year>1988</year>, pp 19&#x02013;39.</mixed-citation></ref><ref id="r14"><label>14</label><mixed-citation publication-type="journal"><person-group><name><surname>Stuart</surname><given-names>M</given-names></name><name><surname>Benvenuti</surname><given-names>F</given-names></name><name><surname>Macko</surname><given-names>R</given-names></name><etal>et
al.</etal></person-group>: <article-title>Community-based adaptive physical activity
program for chronic stroke: feasibility, safety, and efficacy of the Empoli
model</article-title>. <source>Neurorehabil Neural Repair</source>, <year>2009</year>,
<volume>23</volume>: <fpage>726</fpage>&#x02013;<lpage>734</lpage>. <pub-id pub-id-type="pmid">19318465</pub-id></mixed-citation></ref><ref id="r15"><label>15</label><mixed-citation publication-type="journal"><person-group><name><surname>Westlake</surname><given-names>KP</given-names></name><name><surname>Patten</surname><given-names>C</given-names></name></person-group>:
<article-title>Pilot study of Lokomat versus manual-assisted treadmill training for
locomotor recovery post-stroke</article-title>. <source>J Neuroeng Rehabil</source>,
<year>2009</year>, <volume>6</volume>: <fpage>18</fpage>. <pub-id pub-id-type="pmid">19523207</pub-id></mixed-citation></ref><ref id="r16"><label>16</label><mixed-citation publication-type="journal"><person-group><name><surname>Vazzana</surname><given-names>R</given-names></name><name><surname>Bandinelli</surname><given-names>S</given-names></name><name><surname>Lauretani</surname><given-names>F</given-names></name><etal>et
al.</etal></person-group>: <article-title>Trail Making Test predicts physical impairment
and mortality in older persons</article-title>. <source>J Am Geriatr Soc</source>,
<year>2010</year>, <volume>58</volume>: <fpage>719</fpage>&#x02013;<lpage>723</lpage>.
<pub-id pub-id-type="pmid">20398153</pub-id></mixed-citation></ref><ref id="r17"><label>17</label><mixed-citation publication-type="journal"><person-group><name><surname>Guralnik</surname><given-names>JM</given-names></name><name><surname>Ferrucci</surname><given-names>L</given-names></name><name><surname>Simonsick</surname><given-names>EM</given-names></name><etal>et
al.</etal></person-group>: <article-title>Lower-extremity function in persons over the
age of 70 years as a predictor of subsequent disability</article-title>. <source>N Engl
J Med</source>, <year>1995</year>, <volume>332</volume>:
<fpage>556</fpage>&#x02013;<lpage>561</lpage>. <pub-id pub-id-type="pmid">7838189</pub-id></mixed-citation></ref><ref id="r18"><label>18</label><mixed-citation publication-type="journal"><person-group><name><surname>Corrigan</surname><given-names>D</given-names></name><name><surname>Bohannon</surname><given-names>RW</given-names></name></person-group>:
<article-title>Relationship between knee extension force and stand-up performance in
community-dwelling elderly women</article-title>. <source>Arch Phys Med
Rehabil</source>, <year>2001</year>, <volume>82</volume>:
<fpage>1666</fpage>&#x02013;<lpage>1672</lpage>. <pub-id pub-id-type="pmid">11733880</pub-id></mixed-citation></ref><ref id="r19"><label>19</label><mixed-citation publication-type="journal"><person-group><name><surname>Takai</surname><given-names>Y</given-names></name><name><surname>Ohta</surname><given-names>M</given-names></name><name><surname>Akagi</surname><given-names>R</given-names></name><etal>et
al.</etal></person-group>: <article-title>Sit-to-stand test to evaluate knee extensor
muscle size and strength in the elderly: a novel approach</article-title>. <source>J
Physiol Anthropol</source>, <year>2009</year>, <volume>28</volume>:
<fpage>123</fpage>&#x02013;<lpage>128</lpage>. <pub-id pub-id-type="pmid">19483373</pub-id></mixed-citation></ref></ref-list></back></article>